166 related articles for article (PubMed ID: 8424470)
1. Antidepressant treatment of tinnitus patients: report of a randomized clinical trial and clinical prediction of benefit.
Dobie RA; Sakai CS; Sullivan MD; Katon WJ; Russo J
Am J Otol; 1993 Jan; 14(1):18-23. PubMed ID: 8424470
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms.
Sullivan M; Katon W; Russo J; Dobie R; Sakai C
Arch Intern Med; 1993 Oct; 153(19):2251-9. PubMed ID: 8215728
[TBL] [Abstract][Full Text] [Related]
3. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
Kok RM; Nolen WA; Heeren TJ
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant treatment of tinnitus patients. Interim report of a randomized clinical trial.
Dobie RA; Sullivan MD; Katon WJ; Sakai CS; Russo J
Acta Otolaryngol; 1992; 112(2):242-7. PubMed ID: 1604987
[TBL] [Abstract][Full Text] [Related]
5. Treatment of premenstrual depression with nortriptyline: a pilot study.
Harrison WM; Endicott J; Nee J
J Clin Psychiatry; 1989 Apr; 50(4):136-9. PubMed ID: 2647713
[TBL] [Abstract][Full Text] [Related]
6. The effects of alprazolam on tinnitus: a cross-over randomized clinical trial.
Jalali MM; Kousha A; Naghavi SE; Soleimani R; Banan R
Med Sci Monit; 2009 Nov; 15(11):PI55-60. PubMed ID: 19865063
[TBL] [Abstract][Full Text] [Related]
7. A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus.
Westerberg BD; Roberson JB; Stach BA
Am J Otol; 1996 Nov; 17(6):896-903. PubMed ID: 8915419
[TBL] [Abstract][Full Text] [Related]
8. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
9. Ginkgo biloba does not benefit patients with tinnitus: a randomized placebo-controlled double-blind trial and meta-analysis of randomized trials.
Rejali D; Sivakumar A; Balaji N
Clin Otolaryngol Allied Sci; 2004 Jun; 29(3):226-31. PubMed ID: 15142066
[TBL] [Abstract][Full Text] [Related]
10. Treatment of depressed tinnitus patients with nortriptyline.
Sullivan MD; Dobie RA; Sakai CS; Katon WJ
Ann Otol Rhinol Laryngol; 1989 Nov; 98(11):867-72. PubMed ID: 2817678
[TBL] [Abstract][Full Text] [Related]
11. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
[TBL] [Abstract][Full Text] [Related]
12. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
Niklson IA; Reimitz PE; Sennef C
Psychopharmacol Bull; 1997; 33(1):41-51. PubMed ID: 9133750
[TBL] [Abstract][Full Text] [Related]
13. Placebo response and antidepressant clinical trial outcome.
Khan A; Detke M; Khan SR; Mallinckrodt C
J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
[TBL] [Abstract][Full Text] [Related]
14. Maintenance nortriptyline effects on electroencephalographic sleep in elderly patients with recurrent major depression: double-blind, placebo- and plasma-level-controlled evaluation.
Reynolds CF; Buysse DJ; Brunner DP; Begley AE; Dew MA; Hoch CC; Hall M; Houck PR; Mazumdar S; Perel JM; Kupfer DJ
Biol Psychiatry; 1997 Oct; 42(7):560-7. PubMed ID: 9376452
[TBL] [Abstract][Full Text] [Related]
15. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT.
Flint AJ; Rifat SL
Int J Geriatr Psychiatry; 1998 Jan; 13(1):23-8. PubMed ID: 9489577
[TBL] [Abstract][Full Text] [Related]
16. Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" design.
Geller B; Cooper TB; Graham DL; Marsteller FA; Bryant DM
Psychopharmacol Bull; 1990; 26(1):85-90. PubMed ID: 2196631
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
19. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic treatment of major depression for elderly patients in residential care settings.
Katz IR; Simpson GM; Curlik SM; Parmelee PA; Muhly C
J Clin Psychiatry; 1990 Jul; 51 Suppl():41-7; discussion 48. PubMed ID: 2195013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
